EP2249926A2

EP2249926A2 - Compositions comprising phosphoric acid ester and hydrophobically modified, cross-linked anionic polymers

Info

Publication number: EP2249926A2
Application number: EP09706725A
Authority: EP
Inventors: Peter Klug; Waltraud Simsch
Original assignee: Clariant International Ltd
Current assignee: Clariant International Ltd
Priority date: 2008-01-31
Filing date: 2009-01-27
Publication date: 2010-11-17
Also published as: US20100310483A1; WO2009095197A2; WO2009095197A3; DE102008006857A1

Abstract

The invention relates to compositions, comprising the following: I) one or more anionic, cross-linked, hydrophobically modified polymers, wherein the hydrophic modification is carried out by a hydrocarbon group having 6 to 50 carbon atoms, and II) one or more phosphoric acid esters. The compositions are preferably cosmetic, pharmaceutical, or dermatological compositions.

Description

description

Compositions containing phosphoric acid esters and hydrophobically modified, crosslinked, anionic polymers

The present invention relates to compositions comprising hydrophobically modified, crosslinked, anionic polymers and phosphoric acid esters. The compositions may be, for example, cosmetic, pharmaceutical or dermatological compositions.

Anionic polyelectrolytes are now widely used for thickening cosmetic and pharmaceutical products. Crosslinked homopolymers of 2-acrylamido-2-methyl-propane-sulfonates and their use as thickeners are described in EP-A-0 816 403 and WO 98/00094. EP-A-0 510 246 discloses crosslinked copolymers of N-vinylcarboxamides and unsaturated sulfonate-substituted alkylamides. WO 02/43689 describes that hydrophobically modified copolymers based on acrylamido-alkyl sulfonates can be used as thickener and stabilizer in cosmetic compositions.

A common feature of all cross-linked polyelectrolytes is that they cause the establishment of a yield point at sufficient concentration in aqueous systems, which protects suspended solids or liquid phases from creaming or sedimentation. This property is also obtained when the anionic, crosslinked polyelectrolyte carries hydrophobic groups. However, a disadvantage is the relatively high price of anionic polyelectrolytes and the generally very high salt sensitivity. Once the compositions contain larger amounts of salt, the thickening power of these anionic polyelectrolytes is significantly reduced. Nonionic associative thickeners such as polyglycol esters (PEG-150 distearate, PEG-150 polyglyceryl-2-tristearate, PEG-120-methylglucose dioleate) or highly ethoxylated phosphoric acid esters, on the other hand, can cause high viscosity especially with surfactants because of their low molecular weight and are saline-sensitive However, no yield point and are therefore less suitable for stabilizing suspensions or emulsions.

The object was therefore to provide thickener systems which build up a flow limit with a small amount of use and show a good thickening power even with a high salt content in the compositions.

Surprisingly, it has been found that this object is achieved by combinations of hydrophobically modified, anionic, crosslinked polyelectrolytes and associative thickeners based on phosphoric acid. These combinations have a higher viscosity capacity than the respective individual components and at the same time build a higher yield point than can be achieved by the anionic polymer alone. Advantageously, with these combinations, aqueous gels can be produced as a basis for cosmetic, pharmaceutical or dermatological products. These are characterized by increased salt stability and lose their consistency on the skin much slower, thereby enabling a significantly improved sensor technology on the skin.

The invention therefore relates to compositions containing

I) one or more anionic, crosslinked, hydrophobically modified polymers, wherein the hydrophobic modification by a hydrocarbon radical, preferably an alkyl radical, takes place with 6 to 50, preferably 12 to 40 and particularly preferably 18 to 22 carbon atoms, and

II) one or more phosphoric acid esters wherein the one or more phosphoric esters contain

1) one or more structural units derived from substances of component a), wherein the substances of component a) are selected from orthophosphoric acid and one or more of its derivatives, and wherein the one or more derivatives of orthophosphoric acid are preferably selected from polyphosphoric acid, tetraphosphorodecoxide, Phosphorus oxychloride and phosphorus pentachloride,

2) one or more structural units derived from substances of the

Component b), wherein the substances of component b) are selected from one or more compounds of the formula (I)

R ¹ -O- (CH ₂ CH ₂ O) _U (C ₃ H ₆ O) _V (DO) _W -H (I)

wherein

R ^{1 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22, especially preferably 12 to 18 carbon atoms, or represents an aryl group, in particular a phenyl group, which may be substituted by 1 to 3 branched alkyl groups, each of which independently contains 3 to 18 and preferably 4 to 12 carbon atoms,

D represents a linear or branched saturated alkylene group having 4 to 20 carbon atoms, a linear or branched mono- or polyunsaturated alkenylene group having 4 to 20 carbon atoms or -CH (aryl) CH ₂ -, wherein -CH (aryl) CH ₂ preferably -CH (phenyl) CH ₂ -, u is a number from 0 to 200, preferably from 2 to 150, particularly preferably from 5 to 100, particularly preferably from 10 to 50,

v is a number from 0 to 100, preferably from 0 to 50, particularly preferably from 0 to 20 and particularly preferably 0,

w is a number from 0 to 100, preferably from 0 to 20, particularly preferably from 0 to 10 and particularly preferably 0, and

where the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO can be arranged block-wise or randomly distributed from the compounds of the formula (I), and the sum u + v + w> 10, preferably> 20, particularly preferably> 25, particularly preferably> 30,

3) optionally one or more structural units derived from substances of component c), wherein the substances of component c) are selected from one or more diols of the formula (II)

HO- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c -H (II)

wherein

D has the meaning as in formula (I),

a is a number from 0 to 800, preferably from 0 to 250, particularly preferably from 10 to 200 and particularly preferably from 20 to 100,

b is a number from 0 to 100, preferably from 0 to 50 and particularly preferably 0,

c is a number from 0 to 100, preferably from 0 to 20 and particularly preferably 0, wherein the sum of a + b + c> 1, preferably from 5 to 150, and the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of formula (II) may be arranged blockwise or randomly distributed , and

4) optionally one or more structural units derived from a polyol having more than 2 OH groups.

A preferred embodiment of the invention are compositions comprising in component I) one or more anionic, crosslinked, hydrophobically modified polymers obtained by copolymerization of

a) acrylic acid, methacrylic acid or C 1 -C ₄ alkyl esters of acrylic acid or of methacrylic acid,

b) one or more monomers of the formula (III)

R ² - Y- (R ³ - O) _x - R ⁴ (III)

in which R ^{2 is} a vinyl, allyl, acrylic or methacrylic radical, R ^{3 is} (C ₂ -C ₄ ) -alkylene, preferably CH ₂ CH ₂ , R ^{4 is} a linear or branched, saturated alkyl group From 6 to 50, preferably from 12 to 40 and more preferably from 18 to 22, carbon atoms, x is an integer from 0 to 500, preferably from 0 to 25, and Y is O, S or NH, preferably O, and

c) one or more crosslinkers,

d) and optionally one or more further monomers (monomers A1). Particularly preferred are compositions of the invention comprising, in component I) one or more anionic, crosslinked, hydrophobically modified polymers obtained by copolymerization of acrylic acid and CIO ₃ o-alkyl Acrylsäureestern, preferably the (under the trade names Pemulen ^® TR1 Acrylate / Cio-3o alkyl acrylate copolymer), Pemulen ^® TR-2 copolymers (acrylates / Ci _O- 3o alkyl acrylate copolymer), and Carbopol ^® ETD 2020 (acrylates / Ci _O- 3o alkyl acrylate copolymer), and copolymers obtained by copolymerization of acrylic acid or methacrylic acid and alkoxylated C ₆ - ₃ o-alkyl-Acrylsäureestern or C _6-3 -alkyl-methacrylic acid esters, preferably under the trade names Aculyn ^® 22 (Acrylates / Steareth-20 Methacrylate copolymer), Aculyn ^® 28 (Acrylates / beheneth-25 Methacrylate copolymer), Synthalen ^® W copolymers 2000 (acrylates / acrylate copolymer Palmeth-25), and Structure ^® 3001 (acrylates / Ceteth-20 itaconate copolymer).

Particular preference is given to compositions according to the invention comprising, in component I), one or more anionic, crosslinked, hydrophobically modified polymers selected from hydrophobically modified polyacrylates, preferably acrylates / C 1 -C 30 -alkyl acrylate crosspolymer.

A further preferred embodiment of the invention are compositions comprising in component I) one or more anionic, crosslinked, hydrophobically modified polymers selected from hydrophobically modified polysulfonic acids or sulfonates.

Particular preference is given to compositions according to the invention comprising, in component I), one or more anionic, crosslinked, hydrophobically modified polymers obtained by copolymerization of

a) one or more monomers of the formula (IV) (IV) H - Z - SO, X

wherein R ^{5 is} hydrogen, methyl or ethyl, Z is (dC ₈ ) alkylene and X is hydrogen, lithium, sodium, potassium, magnesium, calcium, ammonium, monoalkylammonium, dialkylammonium, trialkylammonium or

Tetraalkylammonium, wherein the alkyl substituents of the ammonium ions are independently (C _r C ₂₂ ) -alkyl radicals or (C ₂ -C ₁₀ ) -hydroxyalkyl radicals, is,

b) one or more monomers of the formula (V)

R ² _ γ_ ( _R ³ _Q) _x R ⁴ (V)

in which R ^{2 is} a vinyl, allyl, acrylic or methacrylic radical, R ^{3 is} (C ₂ -C ₄₎ -alkylene, preferably CH ₂ CH ₂ , R ^{4 is} a linear or branched, saturated alkyl group with from 6 to 50, preferably 12 to 40 and particularly preferably 18 to 22 carbon atoms, x is an integer from 0 to 500, preferably 1 to 50, particularly preferably 6 to 30, and Y is O, S, or NH for O, stands, and

c) one or more crosslinkers,

d) and optionally one or more further monomers (monomers A2).

Among the compositions just described, those which contain in component I) one or more anionic, crosslinked, hydrophobically modified polymers, obtained by copolymerization of a) one or more monomers of the abovementioned formula (IV), in which R ^{5 is} hydrogen, Z is -C (CH ₃ ) ₂ -CH ₂ - and X has the meaning given above under formula (IV),

b) one or more monomers of formula (V) above, wherein R ^{2 is} methacrylic, R ^{3 is} CH ₂ CH ₂ , R ^{4 is} a radical selected from stearyl, lauryl, cocoyl, undecyl, behenyl, cetearyl, cetyl and myristyl, x is an integer from 3 to 50, preferably 6 to 30, and Y is O, S, or NH, preferably O, and

c) one or more crosslinkers,

d) and optionally one or more further monomers (monomers A3).

Accordingly, compositions according to the invention which are particularly preferred in component I) comprise one or more anionic, crosslinked, hydrophobically modified polymers selected from hydrophobically modified copolymers based on acrylamidomethylpropanesulfonic acids or salts thereof, preferably ammonium acrylolydimethyltaurate / steareth-25 crosspolymer (for example Aristoflex ^® HMS, Clariant), or ammonium Acrylolydimethyltaurate / beheneth-25 crosspolymer (z. B. Aristoflex ^® HMB Clariant).

Preferred monomers A1, A2 and A3 are unsaturated carboxylic acids and their anhydrides and salts, and also their esters with aliphatic, cycloaliphatic, arylaliphatic or aromatic alcohols having a carbon number of 1 to 30.

Particularly preferred unsaturated carboxylic acids are acrylic acid,

Methacrylic acid, maleic acid, fumaric acid, crotonic acid, itaconic acid and

Senecioic.

The degree of neutralization of the carboxylic acids can be between 0 and 100%. Further preferred monomers A1, A2 and A3 are open-chain N-vinylamides, preferably N-vinylformamide (VIFA), N-vinylmethylformamide, N-vinylmethylacetamide (VIMA) and N-vinylacetamide; cyclic N-vinylamides (N-vinyllactams) having a ring size of 3 to 9, preferably N-vinylpyrrolidone (NVP) and N-vinylcaprolactam; Amides of acrylic and methacrylic acid, preferably acrylamide, methacrylamide, N, N-dimethylacrylamide, N, N-diethylacrylamide and N, N-diisopropylacrylamide; alkoxylated acrylic and methacrylamides, preferably hydroxymethylmethacrylamide, hydroxyethylmethacrylamide, hydroxypropylmethacrylamide; Succinic mono [2- (methacryloyloxy) ethyl], N, N-dimethylaminomethacrylate,

Diethylaminomethylmethacrylat, acrylic and methacrylamidoglycolic acid, 2- and 4-vinylpyridine, vinyl acetate, glycidyl methacrylate, styrene, acrylonitrile, vinyl chloride, stearyl acrylate, lauryl methacrylate, vinylidene chloride, tetrafluoroethylene, organic acids, their salts and esters, where as acids vinylphosphonic, vinylsulfonic, allylphosphonic, styrenesulfonic and methallylsulfonic acid are preferred.

Preferred as counterions of the salts of the monomers A1, A2 and A3, for example the salts of the unsaturated carboxylic acids, are Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ , quaternary ammonium ions [ HNR ¹ R ² R ³ J ⁺ , wherein R ¹ , R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group with 2 to 22 carbon atoms, a linear or branched mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms, or (EO) _n (PO) _m H, where EO is ethyleneoxy, PO is propyleneoxy, n is 0 to 30 and m is 0 to 30 and n + m> 2. In the ammonium counterions of the salts of the monomers A1, A2 and A3, it may thus z. B. be monoalkylammonium, dialkylammonium or trialkylammonium counterions, wherein the alkyl groups independently z. B. (Ci-C ₂₂ ) -alkyl or (C ₂ -Cio) -Hydroxyalkylreste, or it may be in the ammonium counterions z. B. also be monosubstituted to trisubstituted ethoxylated ammonium compounds with different degrees of ethoxylation.

In a preferred embodiment of the invention, the monomers A1, A2 and A3 are compounds with discrete molecular weight.

In a further preferred embodiment of the invention, the one or more anionic, crosslinked, hydrophobically modified polymers contain no structural units derived from the monomers A1, A2 or A3. The corresponding polymers are each obtained by copolymerization of components a), b) and c).

Suitable crosslinkers are all monomers having at least two olefinic double bonds. Preferred are methylenebisacrylamide; methylenebismethacrylamide; Esters of unsaturated mono- and polycarboxylic acids with polyols, preferably diacrylates and triacrylates or -methacrylates, more preferably butanediol and ethylene glycol diacrylate or methacrylate, trimethylolpropane triacrylate (TMPTA) and trimethylolpropane trimethacrylate (TMPTMA); Allyl compounds, preferably allyl (meth) acrylate, triallyl cyanurate, maleic acid diallyl esters, polyallyl esters, tetraallyloxyethane, triallylamine, tetraallylethylenediamine; Allyl ester of phosphoric acid; and / or vinylphosphonic acid derivatives. Especially preferred are the crosslinking structures resulting from trimethylolpropane triacrylate (TMPTA). The anionic, crosslinked, hydrophobically modified polymers of component I) preferably contain 0.01 to 10 wt .-% of structural units resulting from crosslinking monomers.

The one or more structural units of component II) 1) of the phosphoric acid esters are preferably derived from orthophosphoric acid. These preferred structural units correspond to the formula

O

- O-P = OO

The structural units contained in the phosphoric acid esters of component II) of the compositions according to the invention, which are derived from substances of component b) selected from the compounds of the formula (I), correspond to the formula (I ^' )

R ¹ -O- (CH ₂ CH ₂ O) U (C ₃ H ₆ OMDO) W- (I ^' )

wherein R ¹ , D, u, v and w have the meanings given above under formula (I).

The structural units optionally contained in the phosphoric acid esters of component II) of the compositions according to the invention, which are derived from substances of component c) selected from the compounds of the formula (II), correspond to the formula (M ^' )

-O- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c - (II ^' ) wherein a, b, c and D have the meanings given above under formula (II).

The phosphoric acid esters of component II) contained in the compositions according to the invention contain no oxygen-oxygen bond -O-O-. The structural units derived from the substances of components a), b), optionally c) and optionally the structural units derived from the one or more polyols having more than 2 OH groups are bonded to each other via only one oxygen atom -O-.

R ¹ in the structural units of component II) 2) the phosphoric acid esters derived from the compounds of formula (I) preferably represents a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms.

A further preferred embodiment of the invention are compositions comprising in component II) one or more phosphoric triesters of the formula (III)

(A ₂ O) _y R ₂ I

O

R ₁ - (OA ₁ J _x -OP = O _(m)

O

(A ₃ O) ₂ R ₃

wherein

Ri, R ₂ and R _{3 may be the} same or different and represent a linear or branched, saturated alkyl group of 6 to 30, preferably 8 to 22 and especially preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms or for an aryl group, in particular a phenyl group having 1 to 3 branched alkyl groups each of which may be substituted independently of one another 3 to 18 and preferably 4 to 12 carbon atoms,

the individual groups (OAi) _x , (A ₂ O) _x and (A ₃ O) ₂ each independently consist of units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O and wherein the units CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O within the individual groups (OA ₁ ) X, (A ₂ O) _x and (A ₃ O) ₂ may be arranged block-wise or randomly distributed, and

each of x, y and z independently represents a number from 10 to 150, preferably from 25 to 120, more preferably from 40 to 120 and most preferably from 51 to 100.

In the phosphoric acid triesters of the formula (III) just described, R ¹ , R ² and R ^{3 may be the} same or different and are preferably linear or branched, saturated alkyl groups containing 6 to 30, preferably 8 to 22, more preferably 12 to 18 carbon atoms or for linear or branched, mono- or polyunsaturated alkenyl groups having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms.

A particularly preferred embodiment of the invention are compositions comprising in component II) one or more

Phosphoric acid triesters obtained by reacting phosphoric acid or a phosphoric acid derivative, preferably phosphoric acid, with a fatty alcohol ethoxylate, preferably a fatty alcohol ethoxylate having from 10 to 150 EO units (EO = CH ₂ CH ₂ O), more preferably from 10 to 120 EO units and especially preferably having from 20 to 100 EO units and where the fatty alcohol radicals are derived from alcohols selected from octanol, decanol, dodecanol, Tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl alcohol, fatty alcohols having C-chain cuts 8-22, preferably Cio / C ₁₂ fatty alcohol, C ₂ / Cu-fatty alcohol, C ₂ / C ₁₅ fatty alcohol and Ciβ / Ciβ fatty alcohol , branched fatty alcohols, preferably Guerbet alcohols and monounsaturated fatty alcohols, preferably delta-9-cis-hexadecanol, delta-θ-cis-octadecanol, trans-9-octadecanol and cis-delta-11-octadecanol.

A particularly preferred embodiment of the invention provides compositions containing II in component) one or more phosphoric acid triesters, by reaction of phosphoric acid or a phosphoric acid derivative, preferably phosphoric acid, with Ci ₆ / iβ- fatty alcohol ethoxylates having 10 to 150 ethylene oxide units, preferably with 25 to 120 ethylene oxide units, more preferably C-i6 i ₈ fatty alcohol ethoxylate with 25 ethylene oxide units, C _{6 /} iβ-fatty alcohol ethoxylate with 50 ethylene oxide units were or Ci obtain _6/18 fatty alcohol ethoxylate with 80 ethylene oxide units, _/.

A further preferred embodiment of the invention are compositions according to the invention comprising, in component II), one or more phosphoric acid esters containing structural units derived from compounds of the formula (I) and additionally containing structural units derived from diols of the formula (II).

Preferred among these are compositions according to the invention comprising in component II) one or more phosphoric acid esters which contain structural units derived from diols selected from ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol (PEG) with molecular weights from 200 to 35,000, preferably PEG 200, PEG 300, PEG 400, PEG 600, PEG 800, PEG 1000, PEG 1500, PEG 2000, PEG 3000, PEG 3350, PEG 4000, PEG 6000, PEG 8000, propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, polybutylene glycol, copolymers of ethylene oxide and propylene oxide With

Molecular weights from 200 to 35,000, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,3-hexanediol, 1,4-hexanediol, 1,5-hexanediol, 1, 6-hexanediol and 1, 12-dodecanediol.

The optionally one or more structural units derived from a polyol having more than 2 OH groups of component II) 4) of the Phosphorphorsäureester are preferably derived from glycerol, diglycerol, polyglycerol, pentaerythritol, dipentaerythritol, pentaerythritol, trimethylolpropane, threitol, erythritol, adonite , Arabitol, xylitol, mannitol, sorbitol, inositol, glucose, mannose, fructose, sorbose, arabinose, xylose, ribose, mannopyranose, galactopyranose, glucopyranose, maltose, sucrose, amino sugar,

Ascorbic acid, glucamides and gluconamides, which may also carry one or more alkoxylate groups, and wherein the alkoxylate groups are each composed of one or more units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C 1 H 5 OO units which are within The alkoxylate groups may be arranged block-wise or randomly distributed.

The optionally one or more or more structural units derived from a polyol having more than 2 OH groups of component II) 4) of the Phosphorphorsäureester are particularly preferably derived from pentaerythritol, glycerol and diglycerol, including preferably pentaerythritol, which may also carry one or more alkoxylate groups and wherein the alkoxylate groups are each composed of one or more units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O units, which may each be arranged blockwise or randomly distributed within the alkoxylate groups.

In a preferred embodiment of the invention, the just-mentioned preferred and particularly preferred structural units derived from a polyol having more than 2 OH groups of component II) 4) of the phosphoric acid esters carry no alkoxylate groups. In a further preferred embodiment of the invention, the just mentioned preferred and particularly preferred structural units derived from a polyol having more than 2 OH groups of component M) 4) of the phosphoric acid esters carry one or more alkoxylate groups. Preferred among these phosphoric acid esters are those in which the alkoxylate groups consist of CH ₂ CH ₂ O groups and the number of CH ₂ CH ₂ O groups per polyol molecule with more than 2 OH groups of from 1 to 150, preferably from 5 to 130 and more preferably from 10 to 110.

The one or more phosphoric acid esters of component II) of the compositions according to the invention preferably consist of the structural units II) 1) and II) 2) and optionally II) 3 and II) 4).

In a particularly preferred embodiment of the invention, the phosphoric acid esters of component II) of the invention

Compositions no structural units derived from a polyol having more than 2 OH groups of component II) 4).

Compositions of one or more of the structural units of component II) 1) and one or more structural units of component II) 2).

In a further particularly preferred embodiment of the invention, the phosphoric acid esters of component II) of the invention

Compositions one or more of the structural units of component II) 1), one or more structural units of component II) 2) and one or more structural units of component II) 3). In this embodiment, in turn, the phosphoric acid esters are preferred which consist of one or more of the structural units of component II) 1), one or more structural units of the Component II) 2) and one or more structural units of component II) 3) exist.

The compositions according to the invention comprise the one or more anionic, crosslinked, hydrophobically modified polymers of component I), based on the total weight of the compositions, preferably in an amount of from 0.1 to 3.0% by weight, particularly preferably of 0, From 2 to 2.0% by weight, and more preferably from 0.3 to 1.0% by weight.

The compositions of the invention contain the one or more phosphoric acid esters of component II), based on the total weight of the compositions, preferably in an amount of 0.1 to 5.0 wt .-%, particularly preferably from 0.5 to 3.0 wt .-% and particularly preferably from 0.7 to 2.0 wt .-%.

The inventive combination of phosphoric acid esters and hydrophobically modified, crosslinked, anionic polymers shows a synergistically enhanced thickening power both in aqueous or aqueous-alcoholic compositions and in aqueous-surfactant compositions. Flow limits of 15 to 40 Pa are established.

The compositions according to the invention containing phosphoric acid esters and hydrophobically modified, crosslinked, anionic polymers have an advantageous non-sticky consistency.

In a preferred embodiment of the invention, the compositions are cosmetic, pharmaceutical or dermatological compositions.

In a further preferred embodiment of the invention, the compositions according to the invention, preferably the cosmetic, pharmaceutical or dermatological compositions, are in the form of gels, preferably in the form of hair gels, moisturizing gels, antiperspirant gels, bleach gels, anti-aging gels, self-tanning gels, sunscreen gels, skin whitening gels, conditioners in gel form or disinfecting gels.

A further preferred embodiment of the invention are compositions, preferably cosmetic, pharmaceutical or dermatological compositions, based on aqueous surfactants, particularly preferably shampoos, shower baths, shower gels or bubble baths.

It is particularly advantageous that the thickening power is also pronounced in strongly acidic medium and in electrolyte-containing compositions.

The combinations according to the invention are therefore particularly suitable for thickening and stabilizing acidic compositions, preferably of acidic cosmetic, pharmaceutical or dermatological

Compositions. This can z. As compositions, preferably cosmetic, pharmaceutical or dermatological compositions containing hydroxy acids such as lactic acid, glycolic acid, salicylic acid, citric acid or carboxylic acids such as benzoic acid, sorbic acid or polyglycolic acids in free or partial neutralization. Furthermore, compositions containing vitamin C or vitamin C derivatives, dihydroxyacetone or skin-whitening actives such as arbutin or glycyrrhetinic acid and salts thereof can be stabilized.

In a further preferred embodiment of the invention, the compositions according to the invention have a pH of from 2 to 10, preferably from 2 to 6, particularly preferably from 2.5 to 5 and particularly preferably from 3 to 4.5.

The compositions according to the invention are preferably also electrolyte-containing compositions. In a further preferred embodiment of the invention, the compositions according to the invention therefore comprise one or more electrolytes.

As the electrolyte used are inorganic salts, preferably ammonium or metal salts, more preferably of halides, among them again preferably CaCl ₂ , MgCl ₂ , LiCl, KCl, NaCl, carbonates, hydrogencarbonates, phosphates, sulfates, nitrates, particularly preferably sodium chloride, and / or organic salts, preferably ammonium or metal salts, particularly preferably glycolic acid, lactic acid, citric acid, tartaric acid, mandelic acid, salicylic acid, ascorbic acid, pyruvic acid, fumaric acid, retinoic acid, sulfonic acids, benzoic acid, kojic acid, fruit acid, malic acid, gluconic acid or galacturonic acid.

As electrolyte, the compositions according to the invention may also contain mixtures of different salts.

The electrolyte-containing compositions according to the invention also include aqueous antiperspirant formulations comprising aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts.

The content of the one or more electrolytes in the compositions according to the invention, based on the total composition according to the invention, is preferably from 0.1 to 20.0% by weight, more preferably from 0.2 to 10.0% by weight. %, and more preferably from 0.5 to 5.0% by weight.

It is very advantageous that the compositions according to the invention which contain oxidizing agents, preferably hydrogen peroxide, for example hair colorants, both thicken and stabilize.

In a further preferred embodiment of the invention, the compositions according to the invention contain hydrogen peroxide or Hydrogen peroxide-releasing substances. These compositions are preferably in the form of gels.

Suitable hydrogen peroxide-releasing substances are preferably inorganic peracids, preferably peroxosulphuric acid,

Peroxodisulfuric acid, peroxocarbonates, and organic peracids, preferably peracetic acid.

In a further preferred embodiment of the invention, the compositions according to the invention are acidic hydrogen peroxide bleaching gels or creams.

The compositions according to the invention may contain anionic, cationic, nonionic, ampholytic surfactants and / or betaine surfactants. The total amount of the surfactants used in the compositions according to the invention (for example in the case of rinse-off products), based on the finished compositions according to the invention, is preferably 1 to 70% by weight, particularly preferably 5 to 40% by weight. and particularly preferably 10 to 35% by weight.

Preferred anionic surfactants are (C ₁₀ -C ₂₂ ) -alkyl and alkylene carboxylates, alkyl ether carboxylates, fatty alcohol sulfates, fatty alcohol ether sulfates, alkylamide sulfates and sulfonates, fatty acid alkylamide polyglycol ether sulfates, alkanesulfonates and hydroxyalkanesulfonates, olefin sulfonates, acyl esters of isethionates, α-sulfofatty acid esters, alkylbenzenesulfonates, alkylphenol glycol ether sulfonates,

Sulfosuccinates, sulfosuccinic acid half esters and diesters, fatty alcohol phosphates, fatty alcohol ether phosphates, protein-fatty acid condensation products, alkyl monoglyceride sulfates and sulfonates, alkyl glyceride ether sulfonates, fatty acid methyltaurides, fatty acid sarcosinates, sulforicinoleates, acylglutamates and acylglycinates. These compounds and their mixtures are in the form of their water-soluble or water-dispersible salts, for example, the sodium, potassium, magnesium, ammonium, mono-, di- and triethanolammonium and analog alkylammonium salts.

The amount of anionic surfactants in the inventive

Compositions are preferably from 2 to 30 wt .-%, particularly preferably from 5 to 25 wt .-% and particularly preferably from 12 to 22 wt .-%, based on the finished compositions.

Preferred cationic surfactants are quaternary ammonium salts, such as di- (C ₈ -C 4) -alkyldimethylammonium chloride or bromide, preferably di (C ₈ -C ₂₂ ) -alkyldimethylammonium chloride or bromide; (C 1 -C 4) -alkyldimethylammonium chloride or bromide; (Ca _2-C2) alkyl-trimethyl ammonium chloride or bromide, preferably cetyltrimethylammonium chloride or bromide, and (Ca-C ₂₂₎ - alkyl-trimethyl ammonium chloride or bromide; (Cio-C ₂₄₎ alkyl dimethyl benzyl ammonium chloride or bromide, preferably (C ₂ -C ₈₎ alkyl-dimethyl benzyl ammonium chloride, (C ₈ -C 22) alkyl-dimethyl-hydroxyethyl ammonium chloride, - phosphate, sulfate, lactate, (C ₈ -C 22) alkylamidopropyltrimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ -C ₂ 2-alkanoyl-oxyethyl) -dimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ C22 alkanoyl oxyethyl) hydroxyethyl methyl ammonium chloride, methosulfate.

The amount of cationic surfactants in the compositions according to the invention is preferably from 0.1 to 10% by weight, more preferably from 0.5 to 7% by weight and especially preferably from 1 to 5% by weight, based on the finished compositions.

Preferred nonionic surfactants are fatty alcohol ethoxylates (alkylpolyethylene glycols); Alkylphenolpolyethylenglykole; Fatty amine ethoxylates (alkylamino polyethylene glycols); Fatty acid ethoxylates (acyl polyethylene glycols); Polypropylenglykolethoxylate (Pluronics ^®); fatty acid, (Fettsäureamidpolyethylenglykole); Saccharoseester; Sorbitol esters and sorbitan esters and their polyglycol ethers, and Cβ-C ₂₂ -Alkylpolyglucoside.

The amount of nonionic surfactants in the compositions according to the invention (for example in the case of rinse-off products) is preferably in the range from 1 to 20% by weight, more preferably from 2 to 10% by weight and most preferably from 3 to 7 wt .-%, based on the finished compositions.

Furthermore, the compositions of the invention may contain amphoteric surfactants. These may be described as derivatives of long chain secondary or tertiary amines having an alkyl group of 8 to 18 carbon atoms and in which another group is substituted with an anionic group that mediates water solubility, such as. B. with a carboxyl, sulfate or sulfonate group. Preferred amphoteric surfactants are N- (C ₂ -C ₈₎ alkyl-beta-aminopropionates, and N- (C ₂ -C ₈₎ alkyl-beta-iminodipropionates as alkali metal and mono-, di- and trialkylammonium salts; Suitable further surfactants are also amine oxides. These are oxides of tertiary amines with a long-chain group of 8 to 18 carbon atoms and two mostly short-chain alkyl groups with 1 to 4 carbon atoms. Preferably the C 10 to C ₈ alkyl dimethyl, Fettsäureamidoalkyl- are for example, dimethylamine here.

Another preferred group of surfactants are betaine surfactants, also called zwitterionic surfactants. These contain in the same molecule a cationic group, in particular an ammonium group and an anionic group containing a

Carboxylate group, sulfate group or sulfonate group may be. suitable

Betaines are preferably alkylbetaines such as coco-betaine or

Fatty acid alkylamidopropyl betaines, for example

Kokosacylamidopropyldimethylbetain or the Ci ₂ - to Ci ₈ -Dimethylaminohexanoate or the C10 to Cie-Acylamidopropandimetylbetaine. The amount of the amphoteric surfactants and / or betaine surfactants in the compositions according to the invention is preferably from 0.5 to 20 wt .-% and particularly preferably from 1 to 10 wt .-%, based on the finished compositions.

Preferred surfactants are lauryl sulfate, laureth sulfate, cocoamidopropyl betaine, alkyl betaines such as coco-betaine, sodium cocoyl glutamate and lauroamphoacetate.

In a further preferred embodiment of the invention, the compositions according to the invention additionally contain, as foam-enhancing agents, co-surfactants from the group of the alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazoliniumbetaines and sulfobetaines, amine oxides, fatty acid alkanolamides and polyhydroxyamides.

In a preferred embodiment of the invention, the compositions according to the invention, preferably the cosmetic, pharmaceutical or dermatological compositions, comprise one or more surfactants.

The compositions of the invention may be used as further auxiliaries and additives oil body, silicone oils, waxes, emulsifiers, co-emulsifiers, solubilizers, stabilizers, cationic polymers, film formers, thickeners, gelling agents, superfatting agents, moisturizers, antimicrobial agents, biogenic agents, astringents, deodorants, Sunscreen, antioxidants, humectants, solvents, dyes, fragrances, pearlescing agents, opacifiers and / or water-soluble silicones.

The oil bodies can advantageously be selected from the groups of triglycerides, natural and synthetic fatty substances, preferably esters of

Fatty acids with low C-number alcohols, e.g. B. with isopropanol, propylene glycol or Glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids or from the group of alkyl benzoates, and natural or synthetic hydrocarbon oils.

In consideration triglycerides come from linear or branched, saturated or unsaturated, optionally hydroxylated, C ₈ -C ₃₀ fatty acids, in particular vegetable oils, such as sunflower, corn, soybean, rice, jojoba, Babusscu-, pumpkin, Grapeseed, sesame, walnut, apricot, orange, wheatgerm, peach, macadamia, avocado, sweet almond, meadowfoam, castor, olive, peanut, rapeseed and coconut oils, and synthetic triglyceride oils, e.g. , The commercial product myritol ^® 318. Also Hydrogenated triglycerides are preferred. It is also possible to use oils of animal origin, for example beef tallow, perhydrosqualene, lanolin.

Another class of preferred oil bodies are the benzoic acid esters of linear or branched C _8-22 alkanols, e.g. For example, the commercial products Finsolv ^® SB (isostearyl benzoate), Finsolv ^® TN (Ci ₂ -C ₁₅ alkyl benzoate) and Finsolv ^® EB (Ethylhexylbenzoat).

Another class of preferred oil bodies are the dialkyl ethers having a total of 12 to 36 carbon atoms, in particular having 12 to 24 carbon atoms, such as. As di-n-octyl ether (Cetiol ^® OE), di-n-nonyl ether, di-n-decyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl-n-octyl ether, n-octyl n -decyl ether, n-decyl n-undecyl ether, n-undecyl-n-dodecyl ether and n-hexyl n-undecyl ether, di-3-ethyldecyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methylpentyl-n-octyl ether and di-tert-butyl ether and di-iso-pentyl ether.

Also suitable are branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms, for. B. isostearyl alcohol, and Guerbet alcohols. Another class of preferred oil bodies are hydroxycarboxylic acid alkyl esters. Preferred hydroxycarboxylic acid alkyl esters are full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Further basically suitable esters of the hydroxycarboxylic acids are esters of β-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. As the alcohol component of these esters are primary, linear or branched aliphatic alcohols having 8 to 22 carbon atoms. The esters of Ci ₂ -Ci ₅ fatty alcohols are particularly preferred. Esters of this type are commercially available, e.g. B. under the trade name Cosmacol ^® the EniChem, Augusta Industriale.

Another class of preferred oily substances are dicarboxylic acid esters of linear or branched C ₂ -C-ιo-alkanols, such as di-n-butyl adipate (Cetiol ^® B), di- (2-ethylhexyl) - adipate and di- (2-ethylhexyl) succinate and diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di (2-ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol dicaprylate, and di-isotridecyl acelate.

Likewise preferred oil bodies are symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC).

Another class of preferred oil components are the esters of dimers of unsaturated C ₁₂ -C ₂₂ fatty acids (dimer fatty acids) with monohydric linear, branched or cyclic _C2 -C ₈ alkanols or with polyhydric linear or branched _C2-C6 alkanols.

Another class of preferred oil bodies are hydrocarbon oils, for example those with linear or branched, saturated or unsaturated C ₇ -C ₄₀ -carbon chains, for example Vaseline, dodecane, isododecane, cholesterol, Lanolin, synthetic hydrocarbons such as polyolefins, in particular polyisobutene, hydrogenated polyisobutene, polydecane, and hexadecane, isohexadecane, paraffin oils, isoparaffin oils, z. As the commercial products of Permethyl ^® series, squalane, squalene, and alicyclic hydrocarbons, eg. For example, the commercial product 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), ozokerite, and ceresin.

Dimethylpolysiloxanes and cyclomethicones, polydialkylsiloxanes R ₃ SiO (R ₂ SiO) _x SiR ₃ , where R is methyl or ethyl, particularly preferably methyl, and x is a number from 2 to 500, are preferably available for silicone oils or waxes , for example, under the trade name Vicasil (General Electric Company), DOW CORNING 200, DOW CORNING 225, DOW CORNING 200 (Dow Corning Corporation), available dimethicone, and under SilCare® ^® Silicone 41M65, SilCare® ^® Silicone 41M70, SilCare® ^® Silicone 41M80 (Clariant) available dimethicones, stearyldimethylpolysiloxane, C _2O- C ₂₄ -AI kyl- dimethylpolysiloxane, C ₂₄ -C ₂₈ alkyl-dimethylpolysiloxane, but also under SilCare ^® Silicone 41 M40, SilCare ^® Silicone 41M50 (Clariant) available Methicone, continue Trimethylsiloxysilicate [(CH ₂ ) ₃ SiO) 1/2] _x [SiO 2] y, where x is a number from 1 to 500 and y is a number from 1 to 500, dimethiconols R ₃ SiO [R ₂ SiO] _x SiR ₂ OH and HOR ₂ SiO [R ₂ SiO] _x SiR ₂ OH, where R is methyl or ethyl and x is a number up to 500, polyalkylaryl siloxanes, for example those sold under the trade names SF 1075 METHYLPHENYL FLUID (General Electric Company) and 556 COSMETIC GRADE PHENYL TRIMETHICONE FLUID ( Dow Corning Corporation) available polymethylphenylsiloxanes, polydiarylsiloxanes, silicone resins, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine and / or alkyl-modified silicone compounds, and polyethersiloxane copolymers.

The compositions according to the invention may include waxes, for example paraffin waxes, microwaxes and ozokerites, beeswax and its partial fractions and the beeswax derivatives, waxes from the group of homopolymeric polyethylenes or copolymers of α-olefins, and natural waxes, such as Rice wax, candellila wax, carnauba wax, Japan wax or shellac wax.

As emulsifiers, co-emulsifiers and solubilizers non-ionic, anionic, cationic or amphoteric surface-active compounds can be used.

Suitable nonionic surface-active compounds are preferably addition products of from 0 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide to linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids having from 12 to 22 carbon atoms, to alkylphenols having from 8 to 15 C atoms in the alkyl group and on sorbitol or sorbitol esters; (Ci ₂ -Ci ₈ ) fatty acid mono- and diesters of addition products of 0 to 30 moles of ethylene oxide with glycerol; Glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and optionally their ethylene oxide addition products; Addition products of 15 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil; Polyol and in particular polyglycerol esters, such as. Polyglycerol polyricinoleate and polyglycerol poly-12-hydroxy stearate. Also preferably suitable are ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides and mixtures of compounds of several of these classes of substances.

Suitable ionogenic co-emulsifiers are e.g. anionic emulsifiers, such as mono-, di- or tri-phosphoric acid esters, soaps (for example sodium stearate), fatty alcohol sulfates but also cationic emulsifiers such as mono-, di- and tri-alkyl quats and their polymeric derivatives.

Of amphoteric emulsifiers are preferably available Alkylaminoalkylcarbonsäuren, betaines, sulfobetaines and imidazoline derivatives. Particular preference is given to using fatty alcohol ethoxylates selected from the group consisting of the ethoxylated stearyl alcohols, isostearyl alcohols, cetyl alcohols, isocetyl alcohols, oleyl alcohols, lauryl alcohols, isolauryl alcohols, cetylstearyl alcohols, in particular polyethylene glycol (13) stearyl ether, polyethylene glycol (14) stearyl ether, polyethylene glycol (15) stearyl ether, polyethylene glycol ( 16) stearyl ether, polyethylene glycol (17) stearyl ether, polyethylene glycol (18) stearyl ether, polyethylene glycol (19) stearyl ether, polyethylene glycol (20) stearyl ether, polyethylene glycol (12) isostearyl ether, polyethylene glycol (13) isostearyl ether, polyethylene glycol (14) isostearyl ether, polyethylene glycol (15) isostearyl ether, polyethylene glycol (16) isostearyl ether, polyethylene glycol (17) isostearyl ether, polyethylene glycol (18) isostearyl ether, polyethylene glycol (19) isostearyl ether, polyethylene glycol (20) isostearyl ether, polyethylene glycol (13) cetyl ether, polyethylene glycol (14) cetyl ether, polyethylene glycol (15) cetyl ether, polyethylene glycol (16 cetyl ether, polyethylene glycol (17) cetyl ether, polyethylene glycol (18) cetyl ether, polyethylene glycol (19) cetyl ether, polyethylene glycol (20) cetyl ether, polyethylene glycol (13) isocetyl ether, polyethylene glycol (14) isocetyl ether, polyethylene glycol (15) isocetyl ether, polyethylene glycol (16) isocetyl ether , Polyethylene glycol (17) isocetyl ether, polyethylene glycol (18) isocetyl ether, polyethylene glycol (19) isocetyl ether, polyethylene glycol (20) isocetyl ether, polyethylene glycol (12) oleyl ether, polyethylene glycol (13) oleyl ether, polyethylene glycol (14) oleyl ether, polyethylene glycol (15) oleyl ether, polyethylene glycol (12) lauryl ether, polyethylene glycol (12) isolauryl ether, polyethylene glycol (13) cetyl stearyl ether, polyethylene glycol (14) cetyl stearyl ether, polyethylene glycol (15) cetyl stearyl ether, polyethylene glycol (16) cetyl stearyl ether, polyethylene glycol (17) cetyl stearyl ether, polyethylene glycol (18) cetyl stearyl ether, polyethylene glycol (19 ) cetylstearyl ether.

Also preferred are fatty acid ethoxylates selected from the group of ethoxylated stearates, isostearates and oleates, in particular polyethylene glycol (20) stearate, polyethylene glycol (21) stearate, Polyethylene glycol (22) stearate, polyethylene glycol (23) stearate, polyethylene glycol (24) stearate, polyethylene glycol (25) stearate, polyethylene glycol (12) isostearate, polyethylene glycol (13) isostearate, polyethylene glycol (14) isostearate, polyethylene glycol (15) isostearate, polyethylene glycol ( 16) isostearate, polyethylene glycol (17) isostearate, polyethylene glycol (18) isostearate, polyethylene glycol (19) isostearate, polyethylene glycol (20) isostearate, polyethylene glycol (21) isostearate, polyethylene glycol (22) isostearate, polyethylene glycol (23) isostearate, polyethylene glycol (24) isostearate, polyethylene glycol (25) isostearate, polyethylene glycol (12) oleate, polyethylene glycol (13) oleate, polyethylene glycol (14) oleate, polyethylene glycol (15) oleate,

Polyethylene glycol (16) oleate, polyethylene glycol (17) oleate, polyethylene glycol (18) oleate, polyethylene glycol (19) oleate, polyethylene glycol (20) oleate.

As the ethoxylated alkyl ether carboxylic acid or its salts, the sodium laureth-11-carboxylate can be advantageously used.

As ethoxylated triglycerides can advantageously polyethylene glycol (60) Evening Primose

Glycerides are used.

Furthermore, it is advantageous, the Polyethylenglykolglycerinfettsäureester from

Group of polyethylene glycol (20) glyceryl laurate,

Polyethylene glycol / glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate,

Polyethylene glycol (20) glyceryl isostearate and polyethylene glycol (18) glyceryl oleate / cocoate to choose.

Among the sorbitan esters are particularly suitable

Polyethylene glycol (20) sorbitan monolaurate, polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate. Particularly advantageous co-emulsifiers are glyceryl monostearate, glyceryl monooleate, diglyceryl monostearate, glyceryl isostearate, polyglyceryl-3-oleate, polyglyceryl-3-diisostearate, polyglyceryl-4-isostearate, polyglyceryl-2-dipolyhydroxystearate, polyglyceryl-4-dipolyhydroxystearate, PEG-30-dipolyhydroxystearate, diisostearoylpolyglyceryl 3-diisostearate, glycol distearate and polyglyceryl-3-dipolyhydroxystearate, sorbitan monoisostearate, sorbitan stearate, sorbitan oleate, sucrose distearate, lecithin, PEG-7 hydrogenated castor oil, cetyl alcohol, stearyl alcohol, behenyl alcohol, isobehenyl alcohol and

Polyethylene glycol (2) stearyl ether (steareth-2), alkyl methicone copolyols and alkyl dimethicone copolyols, especially cetyl dimethicone copolyol, lauryl methicone copolyol.

The compositions of the invention may contain one or more of the emulsifiers, co-emulsifiers or solubilizers in amounts of 0.1 to 20 wt .-%, preferably 1 to 15 wt .-% and particularly preferably 3 to 10 wt .-%, based on the finished compositions.

As stabilizers metal salts of fatty acids, such as. As magnesium, aluminum and / or zinc stearate, preferably in amounts of 0.1 to 10 wt .-%, preferably 0.5 to 8 wt .-% and particularly preferably 1 to 5 wt .-%, based on the finished compositions.

Suitable cationic polymers are those known by the INCI name "Polyquaternium", in particular Polyquaternium-31, Polyquaternium-16, Polyquaternium-24, Polyquaternium-7, Polyquaternium-22, Polyquaternium-39,

Polyquaternium-28, Polyquaternium-2, Polyquaternium-10, Polyquaternium-11, as well as Polyquaternium 37 & mineral oil & PPG trideceth (Salcare SC95), PVP-dimethylaminoethyl methacrylate copolymer, guar hydroxypropyl triammonium chlorides, as well as calcium alginate and ammonium alginate. Furthermore, it is possible to use cationic cellulose derivatives; cationic starch; Copolymers of diallyl ammonium salts and acrylamides; quaternized vinylpyrrolidone A / inylimidazole polymers; Condensation products of polyglycols and amines; quaternized collagen polypeptides; quaternized wheat polypeptides; polyethyleneimines; cationic silicone polymers, such as. B. amidomethicones; Copolymers of adipic acid and dimethylaminohydroxy-propyldiethylenetriamine; Polyaminopolyamide and cationic chitin derivatives such as chitosan.

The compositions according to the invention may contain one or more of the abovementioned cationic polymers in amounts of from 0.1 to 5% by weight, preferably from 0.2 to 3% by weight and more preferably from 0.5 to 2% by weight, based on the finished compositions.

Furthermore, the compositions according to the invention may contain film formers which, depending on the intended use, are selected from salts of phenylbenzimidazole sulphonic acid, water-soluble polyurethanes, for example C 10-polycarbamylpolyglyceryl ester, polyvinyl alcohol, water-soluble

Acrylic acid polymers / copolymers or their esters or salts, for example partial acrylic or methacrylic acid, water-soluble cellulose, for example hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, water-soluble quaternium, polyquaternium, carboxyvinyl polymers, such as carbomers and their salts, polysaccharides, for example polydextrose and glucan, vinyl acetate / Crotonat, for example, under the trade name Aristoflex ^® A 60 (Clariant) available.

The compositions according to the invention may contain one or more film formers in amounts of from 0.1 to 10% by weight, preferably from 0.2 to 5% by weight and more preferably from 0.5 to 3% by weight, based on the finished product Compositions included.

The desired viscosity of the compositions can be adjusted by adding further thickeners and gelling agents. Be considered preferably cellulose ethers and other cellulose derivatives (for example carboxymethylcellulose, hydroxyethylcellulose), gelatin, starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, agar-agar, tragacanth or dextrin derivatives, in particular dextrin esters. Also suitable are metal salts of fatty acids, preferably having 12 to 22 carbon atoms, for example sodium stearate, sodium palmitate, sodium laurate, sodium arachidates, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, hydroxyfatty acids, for example 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid; Dibenzal sorbitol and alcohol-soluble polyamides and polyacrylamides or mixtures thereof. Furthermore, crosslinked and uncrosslinked polyacrylates such as carbomer, sodium polyacrylates or sulfonic acid-containing polymers such as Ammoniumacryloyldimethyltaurate / VP copolymer can be used.

The compositions according to the invention preferably contain 0.01 to

20 wt .-%, particularly preferably 0.1 to 10 wt .-%, particularly preferably 0.2 to 3 wt .-% and very particularly preferably 0.4 to 2 wt .-% of thickeners or gelling agents, based on the finished compositions according to the invention.

Lanolin and lecithin, nonethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, mono-, di- and triglycerides and / or fatty acid alkanolamides, the latter also serving as foam stabilizers, which are preferably used in amounts of 0, may preferably be used as superfatting agents , 01 to 10 wt .-%, particularly preferably from 0.1 to 5 wt .-% and particularly preferably from 0.5 to 3 wt .-% are used, based on the finished compositions of the invention.

Antimicrobial agents include cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-laurylsarcosinate, sodium N-palmethyl sarcosinate, lauroylsarcosine, N-myristoylglycine, potassium N- Laurylsarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium chloride, 2,4,4'-TnChIOrO ^ ¹ -hydroxydiphenyl ether (triclosan), phenoxyethanol, 1, 5-pentanediol, 1, 6-hexanediol, 3,4,4'-trichlorocarbanilide (triclocarban ), Diaminoalkylamide, for example L-lysinehexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular zinc salts, pyrithiones and their heavy metal salts, in particular zinc pyrithione, zinc phenol sulfate, farnesol, ketoconazole, oxiconazole, bifonazoles, butoconazoles, cloconazoles, clotrimazoles, econazoles, enilconazoles, fenticonazoles, isoconazoles, Miconazole, sulconazole, Tioconazole, fluconazole, itraconazole, Terconazole, naftifine and terbinafine, selenium disulphide and Octopirox® ^®, iodopropynylbutylcarbamate, methylchloroisothiazolinone, methylisothiazolinone, Methyldibromo glutaronitrile, AgCl, chloroxylenol, sodium salt of diethylhexyl, sodium benzoate, and phenoxyethanol, benzyl alcohol, Phenoxyisopropan ol, parabens, preferably butyl, ethyl, methyl and propylparaben, and their Na salts, pentanediol, 1,2-octanediol, 2-bromo-2-nitropropane-1,3-diol, ethylhexylglycerol, benzyl alcohol, sorbic acid, Benzoic acid, lactic acid, imidazolidinylurea, diazolidinylurea, dimethyloldimethylhydantoin (DMDMH), sodium salt of hydroxymethylglycinate, hydroxyethylglycine of sorbic acid and combinations of these active substances.

The compositions according to the invention preferably contain the antimicrobial active compounds in amounts of from 0.001 to 5% by weight, more preferably from 0.01 to 3% by weight and especially preferably from 0.1 to 2% by weight, based on the finished compositions ,

The compositions of the invention may further biogenic agents selected from plant extracts such as aloe vera, as well as local anesthetics, antibiotics, anti-inflammatories, anti-allergic agents, corticosteroids, sebostatics, bisabolol ^®, allantoin, phytantriol ^®, proteins, vitamins selected from niacin, biotin, vitamin B2 , Vitamin B3, Vitamin B6, Vitamin B3 derivatives (salts, Acids, esters, amides, alcohols), vitamin C and vitamin C derivatives (salts, acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, tocopherol and tocopherol acetate, and also vitamin E and / or its derivatives.

The compositions according to the invention may contain biogenic active substances preferably in amounts of from 0.001 to 5% by weight, more preferably from 0.01 to 3% by weight and especially preferably from 0.1 to 2% by weight, based on the finished compositions, contain.

The compositions according to the invention may contain astringents, preferably magnesium oxide, aluminum oxide, titanium dioxide, zirconium dioxide and zinc oxide, oxide hydrates, preferably alumina hydrate (boehmite) and hydroxides, preferably of calcium, magnesium, aluminum, titanium, zirconium or zinc, and aluminum chlorohydrates, preferably in amounts of from 0 to 50 Wt .-%, particularly preferably in amounts of 0.01 to 10 wt .-% and particularly preferably in amounts of 0.1 to 10 wt .-%, based on the finished compositions of the invention. Preferred deodorants are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10 wt .-%, based on the finished compositions of the invention.

The compositions according to the invention may contain, as pigments / micropigments and as sunscreen filters, microfine titanium dioxide, mica-titanium oxide, iron oxides, mica-iron oxide, zinc oxide, silicon oxides, ultramarine blue, chromium oxides.

The compositions of the invention may contain sunscreen filters, preferably selected from 4-aminobenzoic acid, 3- (4'-trimethylammonium) benzylidene-boran-2-one methylsulfate, Camphor benzalkonium methosulfate, SSδ-trimethylcyclohexylsalicylate, 2-hydroxy-4-methoxybenzophenone , 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 ^* - (1,4-phenylenedimethine) -bis (7,7-dimethyl-2-) oxobicyclo [2.2.1] heptane-1-methanesulfonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione, 3- (4 ^% sulfo ) benzyliden-bornan-2-one and its salts, 2-cyano-3,3-diphenyl-acrylic acid (2-ethylhexyl ester), polymers of N- [2 (and 4) - (2-oxoborn-3-ylidene-methyl ) benzyl] acrylamide, 4-methoxy-cinnamic acid 2-ethylhexyl ester, ethoxylated ethyl 4-aminobenzoate, 4-methoxycinnamic acid isoamyl ester, 2,4,6-tris [p- (2-ethylhexyloxycarbonyl ) anilino] -1, 3,5-triazine, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1) (trimethylsilyloxy) - disiloxanyl) propyl) phenol, 4,4 ^l - [(6- [4 - ((1,1-dimethylethyl) amino carbonyl) phenylamino] -1, 3 _{l of} 5-triazine-2,4 -yl) diimino] bis (benzoic acid 2-ethylhexyl ester), benzophenone-3, benzophenone-4 (acid), 3- (4'-methylbenzylidene) - DL-camphor, 3-benzylidene-camphor, 2-ethylhexyl salicylate 4-dimethylaminobenzoic acid 2-ethylhexyl ester, hydroxy-4-methoxybenzophenone-5-sulfonic acid (sulfisobenzone) and the sodium salt , 4-isopropylbenzyl salicylate, N, N _I N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) anilium methyl sulphate, homosalate (INN) oxybenzone (INN), 2-phenylbenzimidazole-5-sulfonic acid and its sodium, Potassium and triethanolamine salts, octylmethoxycinnamic acid, isopentyl-4-methoxycinnamic acid, isoamyl-p-methoxycinnamic acid, 2,4,6-trianilino (p-carbo-2'-ethylhexyl-i'-oxyJ-I .S.-triazine (Octyl triazone) phenol, 2-2 (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (t -methylsilyl) oxy) -disiloxanyl) propyl (drometrizole trisiloxane) benzoic acid, 4,4 - ((6 - ((((1, 1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis, bis (2-ethylhexyl) ester) benzoic acid, 4,4 - ((6 - ((((1, 1-dimethyl-dimethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2 , 4-diyl) diimino) bis _I (2-ethylhexyl) ester) ₎ 3- (4'-methylbenzylidene) -DL-camphor (4-methylbenzylidene camphor), benzylidene-camphor-sulphonic acid, octocrylene, polyacrylamidomethyl-benzylidene-camphor , 2-ethylhexyl salicylate (octyl Salicylate), ethyl 4-dimethyl-aminobenzoate (octyl dimethyl PABA) ₁ PEG-25 PABA, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid (benzophenone-5) and the Na salt, 2.2 'Methylene-bis-6- (2H-benzotriazolyl) -H-tetramethyl-butyl-1-I-I-phenol, sodium salt of 2-2'-bis (1,4-phenylene) 1H-benzimidazole-4,6-disulfonic acid, (1, 3 ₎ 5) -Triazines-2,4-bis ((4- (2-ethylhexyloxy) -2-hydroxy) -phenyl) -6- (4-methoxyphenyl), 2-ethylhexyl-2-cyano -3,3- diphenyl-2-propenoate, glyceryl octanoate, di-p-methoxycinnamic acid, p-aminobenzoic acid and its esters, 4-tert-butyl-4'-methoxydibenzoylmethane _I 4- (2-β-glucopyranoxy) propoxy-2-hydroxybenzophenone, Octyl salicylate, methyl 2,5-diisopropyl cinnamic acid, cinoxate, dihydroxy dimethoxybenzophenone, disodium salt of 2,2'-dihydroxy-4,4'-dinethoxy-5,5'-disulfobenzophenone, dihydroxybenzophenone, 1, 3,4-dimethoxyphenyl 4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl dimethoxybenzylidene-dioxoimidazolidine propionate, methylene-bis-benztriazolyl tetramethyl butylphenol, phenyldibenzimidazole tetrasulfonate, bis-ethylhexyloxyphenol methoxyphenol triazine, tetrahydroxybenzophenones, terephthalylidenedicamphenesulfonic acid, 2 ₎ 4,6- tris [4,2-ethylhexyloxycarbonyl) anilino] -1, 3,5-triazine, methyl-bis (trimethylsiloxy) silyl-isopentyltrimethoxycinnamic acid, amyl-p-dimethylaminobenzoate, amyl-p-dimethylaminobenzoate, 2-ethylhexyl-p dimethylaminobenzoate, isopropyl-p-methoxycinnamic acid / diisopropyl cinnamic acid ester, 2-ethyl hexyl p-methoxycinnamic acid, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and the trihydrate; and 2-hydroxy-4-methoxybenzophenone-5-sulfonate sodium salt and phenylbenzimidazole-sulfonic acid.

The amount of the aforementioned sunscreen filters (one or more compounds) in the compositions is preferably from 0.001 to 30% by weight, more preferably from 0.05 to 20% by weight and most preferably from 1 to 10% by weight, based on the total weight the finished composition.

The compositions according to the invention may contain antioxidants, preferably selected from amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives

Derivatives, peptides such as DL-carnosine, D-carnosine, L-carnosine and their derivatives (eg anserine), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (eg thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and the like Derivatives (eg, esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), as well as sulfoximine compounds (eg buthionine sulfoximines, homocysteinesulfoximine, buthionine sulfones, penta, hexa, heptathionine sulfoximine) in very low tolerated dosages, furthermore Metal) chelators (eg, α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (eg, citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA ₁ EGTA, and the like Derivatives, unsaturated fatty acids and their derivatives (for example γ-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (for example ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. B. Vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and Koniferylbenzoat the benzoin, rutinic acid and derivatives thereof, α-glycosylrutin, ferulic acid, furfurylidenglucitol, carnosine, butylhydroxytoluene, butylated hydroxyanisole, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, trihydroxybutyrophenone, uric acid and their derivatives, mannose and their derivatives, zinc and its derivatives (eg ZnO, ZnSO ₄ ), selenium and its derivatives (eg selenomethionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) , Superoxide dismutase and the inventively suitable derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these substances.

The antioxidants can protect the skin and hair from oxidative stress. Preferred antioxidants are vitamin E and its derivatives as well as vitamin A and its derivatives.

The amount of the one or more antioxidants in the compositions of the invention is preferably from 0.001 to 30% by weight, especially preferably 0.05 to 20 wt .-% and particularly preferably 1 to 10 wt .-%, based on the total weight of the composition.

In addition, humectants selected from the sodium salt of 2-pyrrolidone-5-carboxylate (NaPCA), guanidine; Glycolic acid and its salts, lactic acid and its salts, glucosamines and their salts, lactamide monoethanolamine, acetamido monoethanolamine, urea, hydroxyacids, panthenol and its derivatives, for example D-panthenol (R-2,4-dihydroxy-N- (3-hydroxypropyl) -3 , 3-dimethylbutamide), DL-panthenol, calcium pantothenate, panthetin, pantotheine, panthenylethyl ether, isopropyl palmitate, glycerol and / or sorbitol are used, preferably in amounts of 0.1 to 15 wt .-% and particularly preferably from 0.5 to 5 Wt .-%, based on the finished compositions.

In addition, compositions of the invention may contain organic ^'solvent. In principle, all mono- or polyhydric alcohols are suitable as organic solvents. Alcohols having 1 to 4 carbon atoms, such as ethanol, propanol, isopropanol, n-butanol, i-butanol, t-butanol, glycerol and mixtures of the alcohols mentioned are preferably used. More preferred alcohols are polyethylene glycols having a molecular weight less than 2,000. In particular, use of polyethylene glycol having a molecular weight of between 200 and 600 and up to 45% by weight and polyethylene glycol having a molecular weight of between 400 and 600 in amounts of 5 to 25 wt .-%, in each case based on the finished composition. Other suitable solvents include triacetin (glycerol triacetate) and 1-methoxy-2-propanol.

The dyes and pigments contained in the compositions according to the invention, both organic and inorganic dyes, are selected from the corresponding positive list of the Cosmetics Ordinance or the EC List of cosmetic colorants. Also advantageous are oil-soluble natural dyes such. B. paprika extracts, beta-carotene and cochineal.

Pearlescent pigments, eg. As fish silver (guanine / hypoxanthine mixed crystals from fish scales) and mother of pearl (milled

Mussel shells), monocrystalline pearlescent pigments such. B. Bismuthoxychlorid (BiOCl), layer substrate pigments, z. Example, mica / metal oxide, silver-white Pei luster pigments of TiO ₂ , interference pigments (TiO ₂ , different layer thickness), color luster pigments (Fe ₂ O ₃ ) and combination pigments (TiO ₂ / Fe ₂ O ₃ , TiO ₂ / Cr ₂ O ₃ , TiO ₂ / Berlin Blue, TiO ₂ / Carmine).

In the context of the present invention, effect pigments are to be understood as meaning pigments which, by virtue of their refractive properties, cause particular optical effects. Effect pigments lend the treated surface (skin, hair, mucous membrane) gloss or glitter effects or can optically hide skin irregularities and skin wrinkles through diffuse light scattering. As a particular embodiment of the effect pigments, interference pigments are preferred. Particularly suitable effect pigments are, for example, mica particles coated with at least one metal oxide. In addition to mica, a phyllosilicate, silica gel and other SiO ₂ modi fi cation are suitable as a carrier. A metal oxide frequently used for coating is, for example, titanium oxide, to which iron oxide may be added, if desired. The size and shape (eg spherical, ellipsoidal, flattened, even, uneven) of the pigment particles as well as the thickness of the oxide coating can influence the reflection properties. Other metal oxides, eg. B. bismuth oxychloride (BiOCl), and the oxides of, for example, titanium, in particular the TiO ₂ modifications anatase and rutile, aluminum, tantalum, niobium, zirconium and hafnium. Also with magnesium fluoride (MgF ₂ ) and calcium fluoride (fluorspar, CaF ₂ ) effect pigments can be produced. The effects can be controlled both by the particle size and by the particle size distribution of the pigment ensemble. Suitable particle size distributions range z. From 2 to 50 μm, from 5 to 25 μm, from 5 to 40 μm, from 5 to 60 μm, from 5 to 95 μm, from 5 to 100 μm, from 10 to 60 μm, from 10 to 100 μm, from 10 to 125 μm, and from 20 to 20 μm. 100 μm, 20-150 μm and <15 μm. A broader particle size distribution, e.g. Example, from 20 to 150 microns, glittering effects, while a narrower particle size distribution of <15 microns ensures a uniform silky appearance.

The compositions according to the invention preferably contain effect pigments in amounts of from 0.1 to 20% by weight, more preferably from 0.5 to 10% by weight and particularly preferably from 1 to 5% by weight, based in each case on the total weight of the composition ,

Preferred deodorants are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10 wt .-%, based on the total weight of the compositions of the invention.

As fragrance or perfume oils can individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons are used. Fragrance compounds of the ester type are e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, benzylformate, ethyl-methylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate and benzylsalicylate. The ethers include, for example, benzyl ethyl ether to the aldehydes z. B. the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclic aldehyde, Hydroxycitronellal, Lilial and Bourgeonal, to the ketones z. The alcohols include anethole, citronellol, eugenol, geranion, linalol, phenylethyl alcohol and terpineol; the hydrocarbons mainly include the terpenes and balsams. Preference is given to mixtures various fragrances used, which together create an appealing scent.

Perfume oils may also contain natural fragrance mixtures, such as those available from plant or animal sources, e.g. Pine, citrus, jasmine, lily, rose, or ylang-ylang oil. Also essential oils of lower volatility, which are mostly used as aroma components, are suitable as perfume oils, eg. B. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil and ladanum oil.

As pearlescing component are preferably suitable fatty acid monoalkanolamides, fatty acid dialkanolamides, monoesters or diesters of alkylene glycols, in particular ethylene glycol and / or propylene glycol or its oligomers, with higher fatty acids, such as. As palmitic acid, stearic acid and behenic acid, monoesters or polyesters of glycerol with carboxylic acids, fatty acids and their metal salts, ketosulfones or mixtures of said compounds. Particularly preferred are ethylene glycol distearates and / or polyethylene glycol distearates with an average of 3 glycol units.

If the compositions according to the invention are pearlescing

Compounds containing these are preferably present in an amount of 0.1 to 15 wt .-% and particularly preferably in an amount of 1 to 10 wt .-% in the compositions of the invention, each based on the total weight of the composition.

As acids or alkalis for pH adjustment preferably mineral acids, in particular HCl, inorganic bases, in particular NaOH or KOH, and organic acids, in particular citric acid, are used. The following examples and applications are intended to illustrate the invention without, however, limiting it thereto. All percentages are by weight (% by weight).

Production examples, general working instructions:

Phosphoric acid (85% strength), fatty alcohol ethoxylate and / or diol and / or polyol and in a certain molar ratio are used in the preparation of the phosphoric acid esters contained in the compositions according to the invention. For this purpose, all starting materials are initially charged in a stirred apparatus with a heating mushroom, a descaling unit with a condenser and a vacuum connection. The mixture is heated to 100 ⁰ C, evacuated three times to 100 mbar and then re-aerated with nitrogen. After a further 4 hours of inerting (nitrogen inlet of 20 liters / hour) at 100 ⁰ C, the mixture is heated under nitrogen inlet to 230 ⁰ C and esterified (water discharge). The reaction times are 24 to 42 hours (from 230 ⁰ C

Esterification temperature calculated), in particular 40 hours. The residual acid number is then <3 mg KOH / g. This corresponds to about 93 to 96% conversion (based on starting acid number). After completion of the reaction, the product is cooled to 80 ⁰ C, poured into a dish and crushed the solidified melt.

Phosphoric acid ester 1

Ester from 13.8 g phosphoric acid, 316.1 g polyglycol 4000 and 296.0 g ceteareth-25 (C-16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 3: 2: 5, residual acid number: 1.9 mg KOH / g (94% conversion), ³¹ P-NMR: diesterHyiester = 18/82 (molar ratio). Phosphoric acid ester 2

Ester from 12.7 g phosphoric acid and 701.3 g Ceteareth-50 (C _{16 /} iβ fatty alcohol + 50 mol ethylene oxide) in the molar ratio 1: 3, residual acid number: 0.8 mg KOH / g (97% conversion), ³¹ P-NMR: diester / triester = 13/87 (molar ratio)

The following table shows the synergism of the phosphoric acid esters with hydrophobically modified, anionic, crosslinked polymers in terms of viscosity and yield point formation.

The phosphoric acid esters 1 and 2 were dissolved in water at 60 ⁰ C (1%), the solution was cooled to 25 ⁰ C and then treated with 0.5% Aristoflex ^® HMB (ammonium acryloyldimethyltaurat / Beheneth-25 methacrylate crosspolymer) and by vigorous stirring made a homogeneous gel. For comparison, gels / solutions of the individual components were also prepared.

The viscosity of the solutions was measured using a Brookfield DV-II viscometer, rotational speed of 20 s ^{"measured 1} at 20 ⁰ C. At <100 mPa ^■ s Spindle 2 was used at> 10000 mPa ^• s spindle 5 at> 20000 mPa ^• s Spindle 6.

The yield strengths were determined with a Bohlin rheometer using the Casson method (plot shear rate ¹ ' ² vs. Shear stress ^1/2 ) in the 0-1 s ^"1 shear rate region at 25 ^° C.

Table 1: Viscosity behavior and formation of yield points

From the results listed in Table 1 it can be seen that the inventive combination of the phosphoric acid esters and the anionic, crosslinked, hydrophobically modified polymers both causes a significant increase in the yield strength of the gel, and the viscosity increases significantly under the selected measurement conditions. In addition, the gels are containing

Phosphoric acid ester and anionic, crosslinked, hydrophobically modified polymer clear and offer compared to a gel based only on polysulfonic a significantly improved pick-up, i. The gels can be easily absorbed on the finger without the gel liquefying and slipping off.

formulation Examples

Formulation Example 1 - Vitamin C Gel

A phosphoric acid ester 2 1, 0%

Genapol ^® T 250 (Clariant) 1, 5%

Ceteareth-25 B water ad 100%

C ascorbic acid 3.0%

D Aristoflex ^® HMB (Clariant) 1.2%

Ammonium acryloyldimethyltaurate / beheneth-25

Methacrylate Crosspolymer

production:

Dissolve IA in B with stirring and heating to approx. 50 ^° C.

Give II C in I.

Add III D and stir until a homogeneous gel has formed. Formulation Example 2 - Facial Anti-Aging Gel

A Genapol ^® T 250 (Clariant) 1.5%

Ceteareth-25 phosphoric acid ester 2 (Clariant) 1, 0%

B water ad 100%

C Aristoflex ^® HMB (Clariant) 1, 6%

Ammonium acryloyldimethyltaurate / beheneth-25

Methacrylate Crosspolymer D Glycolic Acid 30% * 6.0%

Preservatives q.s.

* adjusted to pH 4 with NaOH (content based on free glycolic acid)

Preparation: Dissolve I A in B with stirring and gentle heating.

Add II C to I and stir until the gel is free of lumps (about 300 rpm with a finger stirrer).

III Add the components from D to II and stir until the formulation is homogeneous.

Formulation Example 3 - Facial Anti Aging Cream Gel

A phosphoric acid ester 1 1.0% B water ad 100%

C mineral oil 5.0%

SilCare ^® Silicone 31M50 (Clariant) 3.0%

Caprylyl trimethicone

D Aristoflex ^® HMB (Clariant) 1.5% Ammonium Acryloyldimethyltaurate / Beheneth-25

Methacrylate Crosspolymer E glycolic acid 30% * 6.0%

Preservatives q.s.

F Genapol ^® LA 070 (Clariant) 3.0%

Laureth-7 * adjusted to pH 4 with NaOH (content based on free glycolic acid)

production:

Dissolve I A in B with stirring and gentle heating.

II give D to C. Add III I to II and stir until the gel is free of lumps (about 300 rpm with a finger stirrer).

IV Give the components from E to III.

Add V to IV and stir until the formulation is homogeneous.

VI Finally, homogenize the cream gel.

Formulation Example 4 - O / W Self-tanning cream

A Hostaphat CC 100 ^® (Clariant) 1.0% Cetyl Phosphate

Glyceryl stearate 0.5%

Cetearyl alcohol 0.5%

Paraffin oil, n.v. 8.0%

Isopropyl palmitate 7.0% SilCare ^® Silicone 41M15 (Clariant) 1 0%

Caprylyl Methicone

B Aristoflex ^® HMB (Clariant) 0.7%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer C phosphoric acid ester 2 1.0%

D water ad 100%

Hostapon ^® CLG (Clariant) 0.5%

Sodium Lauroyl Glutamate

Glycerin 5.0%

E tocopheryl acetate 1.0%

Perfume 0.2%

Preservative q .S.

F dihydroxyacetone 5.0%

Water 8.0%

G sodium hydroxide solution q.

production:

IA melt at 80 ⁰ C. Stir in B in A.

Dissolve III C in D with stirring and heating to approx. 50 ^° C., then add to II.

IV stir at 30 ⁰ CE in III.

Dissolve V dihydroxyacetone in the water and add F to IV.

Adjust the pH with G to approx. 4, if necessary.

Formulation example 5 - sunscreen cream gel

A Eusolex ^® 232 8.0% Phenylbenzimidazole Sulfonic Acid

B water ad 100%

C phosphoric acid ester 2 1, 0%

D Aristoflex ^® HMB (Clariant) 1.0%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer E Tegosoft TN 5.0%

C12-15 alkyl benzoate

SilCare ^® Silicone 15M50 (Clariant) 4.0%

Phenyl Trimethicone Eusolex ^® 9020 3.0%

methoxydibenzoylmethane

Velsan ^® D8P-3 (Clariant) 3.5%

Isopropyl PPG-2 Isodeceth-7 Carboxylate

F Nipaguard ^® MPA (Clariant) qs Benzyl Alcohol (and) Methylparaben (and) Propylparaben

Genapol ^® LA 070 (Clariant) 1.5%

Laureth-7

SilCare ^® Silicone SEA (Clariant) 0.5%

Trideceth-9 PG-Amodimethicone and Trideceth-12 Perfume q.s.

production:

Mix and neutralize I A and B (adjust the pH to approx. 7.3).

Dissolve II C in I with stirring and gentle heating. Add III D and stir until a homogeneous gel has formed.

IV Mix the components of E, dissolve with gentle heating and then add to III.

V Finally, give F to VI.

Formulation Example 6 - Pigment Shower Bath

A water ad 100%

B organophosphate 1 2.0% C Aristoflex ^® HMB (Clariant) 0.7% Ammonium acryloyldimethyltaurate / beheneth-25

Methacrylate Crosspolymer D Genapol ^® LRO liquid (Clariant) 30.0%

Sodium laureth sulfate perfume 0.5%

Preservatives q.s.

E Hostapon ^® CGN (Clariant) 4.0%

Sodium Cocoyl Glutamate

F Cirebelle 104 0.2% Synthetic Wax

production:

IB solve in A under stirring and heating to about 5O ⁰ C.

Add II C to I and stir until almost homogeneous. III Mix the components of D and stir with stirring. Continue stirring until the formulation is homogeneous.

IV E to III.

Give V to IV.

VI Finally, if necessary, adjust the pH.

Formulation Example 7 - Facial Toner

A glycerol 10.0%

Polyglycol 400 (Clariant) 5.0%

PEG-8

Panthenol 0.5%

Perfume 0.2%

Preservative qs Allantoin (Clariant) 0.1%

Niacinamide 0.1%

Extrapon Hamamelis 1, 0%

Water, Witch Hazel Distillate, SD Alcohol 39-C, Butylene Glycol B Water ad 100%

C phosphoric acid ester 1 0.5%

D Aristoflex ^® HMB (Clariant) 0.2%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer

production:

I dissolve C in B at ca. 70 ^° C.

II Dissolve D with stirring in I.

III addition of the components of A in II.

Formulation Example 8 - Whitening Gel

A water ad 100%

Arginine 1, 10%

B Phosphoric acid ester 2 (Clariant) 2.00%

C dipropylene glycol 8.00%

Genapol ^® C 100 (Clariant) 0.60%

Coceth-10

Sodium citrate * 2H ₂ O 0.09%

Citric acid 10.0% 0.10%

Nipagin M ^® (Clariant) 0.20%

methylparaben

Ascorbic Acid-2-glucoside 2.00% D Aristoflex ^® HMB (Clariant) 1, 50%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer

production:

I Solve the components of A.

II Dissolve B in I at approx. 70 ^° C.

III Dissolve C with stirring in II.

IV Dissolving D in III.

Formulation Example 9 - Make-Up Remover

A Velsan P8-3 ^® (Clariant) 5.0% Isopropyl _2- Ci i ₅ Pareth-9 Carboxylate

B water ad 100%

C Phosphoric acid ester 2 (Clariant) 1, 0%

D Hostapon ^® CGN (Clariant) 2.0%

Sodium Cocoyl Glutamate Genagen ^® CAB (Clariant) 3.0%

Cocamidopropyl betaine allantoin (Clariant) 0.3%

Aristoflex PEA ^® (Clariant) 1.0%

Polypropylene Terephthalate 1, 6 Hexanediol 2.0%

1, 2 propanediol 2.0%

Polyglycol 400 (Clariant) 2.0%

PEG-8 Panthenol 0.5% Lutrol F 127 3.0% Poloxamer 407

Preservatives q.s.

E Aristoflex ^® HMB (Clariant) 0.7%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer

F Genapol ^® LA 070 (Clariant) 2.0%

Laureth-7

Preparation: I Dissolve C in B at ca. 70 ^° C.

II Dissolution of E with stirring in I.

III Dissolving the components of D in II.

IV Solving A in III.

V solving F in IV.

Formulation Example 10 - Deodorant Gel

A Octopirox ^® (Clariant) 0.1% Piroctone Olamine

B Emulsogen ^® HCP 049 (Clariant) 10.0%

PEG-40 Hydrogenated Castor OiI and Propylene Glycol Perfume 0.2%

C water ad 100% D phosphoric acid ester 2 (Clariant) 3.0%

Aristoflex ^® HMB (Clariant) 0.2%

Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer

E citric acid qs production:

Release I A in B.

Dissolve II D in C with stirring and gentle warming, then add Il to I.

III If necessary, adjust the pH to 6.0 with E.

Formulation Example 11 - Hydrogen Peroxide Gel

A organophosphate 1 1, 50% Aristoflex ^® HMB 1.00% Ammonium Acryloyldimethyltaurate / Beheneth-25 Methacrylate Crosspolymer

Genapol ^® T 250 (Clariant) 2.00% Ceteareth-25 B water ad 100%

C phosphoric acid 0.04%

Sodium dihydrogen phosphate 1, 00%

D hydrogen peroxide 30% 18.00%

production:

Dissolve IA in B with stirring and heating to 50 ^° C.

II Add 25 ⁰ CC.

III Add D at room temperature.

Claims

claims

1. Composition comprising:

II) one or more phosphoric acid esters

wherein the one or more phosphoric esters contain

2) one or more structural units derived from substances of component b), wherein the substances of component b) are selected from one or more compounds of the formula (I)

R ^{1 is} -O- (CH ₂ CH ₂ θ) _u (C ₃ H ₆ O) _v (DO) _w -H (I)

wherein

R ^{1 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms or an aryl group, in particular a phenyl group which may be substituted by 1 to 3 branched alkyl groups, each of which independently contains 3 to 18 and preferably 4 to 12 carbon atoms,

D represents a linear or branched saturated alkylene group having 4 to 20 carbon atoms, a linear or branched mono- or polyunsaturated alkenylene group having 4 to 20 carbon atoms or -CH (aryl) CH ₂ -, wherein -CH (aryl) CH ₂ preferably -CH (phenyl) CH ₂ -,

u is a number from 0 to 200, preferably from 2 to 150, particularly preferably from 5 to 100, particularly preferably from 10 to 50,

HO- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c -H (II) embedded image in which

D has the meaning as in formula (I),

c is a number from 0 to 100, preferably from 0 to 20 and particularly preferably 0,

wherein the sum of a + b + c> 1, preferably from 5 to 150, and the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of formula (II) may be arranged blockwise or randomly distributed , and

2. Composition according to claim 1, characterized in that it contains in component I) one or more anionic, crosslinked, hydrophobically modified polymers obtained by copolymerization of

a) acrylic acid, methacrylic acid or C ₁ -C ₄ alkyl esters of acrylic acid or of methacrylic acid,

b) one or more monomers of the formula (III)

R ² - Y- (R ³ - O) _x - R ⁴ (IM) in which R ^{2 is} a vinyl, allyl, acrylic or methacrylic radical, R ^{3 is} (C ₂ -C ₄ ) -alkylene, preferably CH ₂ CH ₂ , R ^{4 is} a linear or branched, saturated alkyl group From 6 to 50, preferably from 12 to 40 and more preferably from 18 to 22, carbon atoms, x is an integer from 0 to 500, preferably from 0 to 25, and Y is O, S or NH, preferably O, and

c) one or more crosslinkers,

d) and optionally one or more further monomers.

3. Composition according to claim 1 or 2, characterized in that it contains in component I) one or more anionic, crosslinked, hydrophobically modified polymers, obtained by copolymerization of

a) one or more monomers of the formula (IV)

CH ₂ = CR ⁵ c ^(IV)

O NH - Z - SO ₃ X

wherein R ^{5 is} hydrogen, methyl or ethyl, Z is (C _r C ₈ ) -alkylene and X is hydrogen, lithium, sodium, potassium, magnesium, calcium, ammonium, monoalkylammonium, dialkylammonium, trialkylammonium or tetraalkylammonium, wherein the alkyl substituents of the ammonium ions independently of one another are (C ₁ -C ₂₂ ) -alkyl radicals or (C ₂ -C ₁₀ ) -hydroxyalkyl radicals,

b) one or more monomers of the formula (V)

R ² _ γ_ (R ³ _Q) _x - R ⁴ (V) in which R ^{2 is} a vinyl, allyl, acrylic or methacrylic radical, R ^{3 is} (C ₂ -C ₄ ) -alkylene, preferably CH ₂ CH ₂ , R ^{4 is} a linear or branched, saturated alkyl group with 6 x is an integer from 0 to 500, preferably 1 to 50, more preferably 6 to 30 and Y is O, S or NH, preferably O, stands, and

c) one or more crosslinkers,

d) and optionally one or more further monomers.

4. The composition according to claim 3, characterized in that in the one or more monomers of the formula (IV) R ^{5 is} hydrogen, Z is -C (CHa) ₂ -CH ₂ - and X is as defined in claim 3 and in which one or more monomers of formula (V) R ^{2 is} methacrylic, R ^{3 is} CH ₂ CH ₂ , R ^{4 is} a radical selected from stearyl, lauryl, cocoyl, undecyl, behenyl, cetearyl, cetyl and myristyl, x is an integer from 3 to 50, preferably from 6 to 30, and Y is O.

5. Composition according to one or more of claims 1 to 4, characterized in that it contains in component II) one or more phosphoric triesters of the formula (III)

(A ₂ O) _x R ₂

O

R ₁ - (OA ₁ J _x -OP = O _(m)

O

(A ₃ O) ₂ R ₃ wherein

Ri, R ₂ and R _{3 may be the} same or different and is a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group with 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms or for an aryl group, in particular a phenyl group, which are substituted by 1 to 3 branched alkyl groups, each independently 3 to 18 and preferably 4 to 12 carbon atoms can, stand,

the individual groups (OAi) _x , (A ₂ O) _y and (A ₃ O) ₂ each independently consist of units selected from CH ₂ CH ₂ O, CaH ₆ O and C ₄ H ₈ O and wherein the units CH ₂ CH ₂ O, CsH ₆ O and C ₄ HaO within the individual groups (OA ₁ ) _X , (A ₂ O) _x and (A ₃ O) ₂ may be arranged block-wise or randomly distributed, and

6. The composition according to one or more of claims 1 to 5, characterized in that it contains in component II) one or more phosphoric triesters obtained by reacting phosphoric acid or a phosphoric acid derivative, preferably phosphoric acid, with a fatty alcohol ethoxylate, preferably a fatty alcohol ethoxylate with 10 to 150 EO units (EO = CH ₂ CH ₂ O), particularly preferably with 10 to 120 EO units and particularly preferably with 20 to 100 EO units and where the fatty alcohol radicals are derived from alcohols selected from octanol, decanol , Dodecanol, tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl, fatty alcohols with C-chain sections between 8 and 22, preferably C ₁₀ / C ₁₂ fatty alcohol, Ci ₂ / Ci ₄ fatty alcohol, Ci ₂ / Ci ₅ fatty alcohol and C ₁₆ / C ₈ fatty alcohol, branched fatty alcohols, preferably Guerbet alcohols and monounsaturated Fatty alcohols, preferably delta-9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol and cis-delta-H-octadecanol.

7. Composition according to one or more of claims 1 to 6, characterized in that they in component II) one or more

Phosphoric triester containing by reaction of phosphoric acid or a phosphoric acid derivative, preferably phosphoric acid, with C-iβ / iβ fatty alcohol ethoxylates having 10 to 150 ethylene oxide units, preferably with 25 to 120 ethylene oxide units, particularly preferably Ciβm fatty alcohol ethoxylate with 25 ethylene oxide units , Ci _{6 /} i ₈ fatty alcohol ethoxylate with 50 ethylene oxide units or Ci _{6 /} iβ fatty alcohol ethoxylate with 80 ethylene oxide units were obtained.

8. Composition according to one or more of claims 1 to 7, characterized in that it contains in component II) one or more phosphoric acid esters which contain structural units which are derived from diols of the formula (II).

9. A composition according to claim 8, characterized in that it contains in component II) one or more phosphoric acid esters which contain structural units derived from diols selected from ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol (PEG) with molecular weights of 200 to 35000, preferably PEG 200, PEG 300, PEG 400, PEG 600, PEG 800, PEG 1000, PEG 1500, PEG 2000, PEG 3000, PEG 3350, PEG 4000, PEG 6000, PEG 8000, propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, Polybutylene glycol, copolymers of ethylene oxide and propylene oxide having molecular weights of 200 to 35,000, 1,2-butanediol, 1,3-butanediol, 1, 4-butanediol, 1,2-pentanediol, 1, 3-pentanediol, 1,4-pentanediol, 1 , 5-pentanediol, 1, 2-hexanediol, 1,3-hexanediol, 1, 4-hexanediol, 1,5-hexanediol, 1, 6-hexanediol and 1, 12-dodecanediol.

Composition according to one or more of Claims 1 to 9, characterized in that it contains the one or more anionic, crosslinked, hydrophobically modified polymers of component I), based on the total weight of the composition, in an amount of from 0.1 to 3.0% by weight, preferably from 0.2 to 2.0% by weight and particularly preferably from 0, 3 to 1, 0 wt -.% Contains.

11. The composition according to one or more of claims 1 to 10, characterized in that it contains the one or more phosphoric acid esters of component II), based on the total weight of the composition, in an amount of 0.1 to 5.0 parts by weight. %, preferably from 0.5 to 3.0 wt .-% and particularly preferably from 0.7 to 2.0 wt .-%.

Composition according to one or more of Claims 1 to 11, characterized in that it is a cosmetic, pharmaceutical or dermatological composition.

13. The composition according to one or more of claims 1 to 12, characterized in that they are in the form of gels, preferably in the form of hair gels, moisturizing gels, antiperspirant gels, bleaching gels, anti-aging gels, Selbstbräunungsgelen, Sonnenschutzgeleπ, skin whitening gels, conditioners in gel form or disinfectant gels.

14. The composition according to one or more of claims 1 to 13, characterized in that it contains hydrogen peroxide or hydrogen peroxide-releasing substances.